AeroLeads people directory · profile

Chitavi (Chloe) Maulloo, Ph.D. Email & Phone Number

IMBA Candidate at IE Business School
Location: New York, United States 13 work roles 2 schools
1 work email found @uchicago.edu LinkedIn matched
✓ Verified August 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email c****@uchicago.edu
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
IMBA Candidate
Location
New York, United States
Company size

Who is Chitavi (Chloe) Maulloo, Ph.D.? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Chitavi (Chloe) Maulloo, Ph.D. is listed as IMBA Candidate at IE Business School, a with 3674 employees, based in New York, United States. AeroLeads shows a work email signal at uchicago.edu and a matched LinkedIn profile for Chitavi (Chloe) Maulloo, Ph.D..

Chitavi (Chloe) Maulloo, Ph.D. previously worked as Biotech and Pharma Equity Research Associate at Scotiabank - Global Banking And Markets and Biotech & Pharma Equity Research Associate at Scotiabank - Global Banking And Markets. Chitavi (Chloe) Maulloo, Ph.D. holds Molecular Engineering, Immunology, Lymphatics from University Of Chicago.

Company email context

Email format at IE Business School

This section adds company-level context without repeating Chitavi (Chloe) Maulloo, Ph.D.'s masked contact details.

*@uchicago.edu
68% confidence

AeroLeads found 1 current-domain work email signal for Chitavi (Chloe) Maulloo, Ph.D.. Compare company email patterns before reaching out.

Profile bio

About Chitavi (Chloe) Maulloo, Ph.D.

Immuno-engineering scientist, founder, and equity research professional looking to apply my subject matter expertise in biotechnology and drug development, analytical, financial modeling, communication, and leadership skills, as well as experience in venture creation and deal support (opportunity sourcing and assessment, valuation, IP agreements, go/no-go decision-making, strategic partnerships) to the following roles:- biotech analyst/ investor in public or private equities or venture capital- business development and portfolio strategy in biotech or pharma- corporate communications and investor relations in biotech- technology licensing and venture creation in academia

Listed skills include Cancer Immunology, Nanoparticles, Inorganic Synthesis, Lymphatics, and 28 others.

Current workplace

Chitavi (Chloe) Maulloo, Ph.D.'s current company

Company context helps verify the profile and gives searchers a useful next step.

IE Business School
Ie Business School
IMBA Candidate
Madrid, ES
Employees
3674
AeroLeads page
13 roles · 15 years

Chitavi (Chloe) Maulloo, Ph.D. work experience

A career timeline built from the work history available for this profile.

Biotech & Pharma Equity Research Associate

Current

Toronto, Ontario, Ca

Building Scotiabank's U.S. biotech and pharma franchise with seasoned analyst, George Farmer

May 2023 - Present

Senior Associate In Biotech Equity Research

New York, Ny, Us

Coverage (Genetic Medicine and Precision Oncology): ACHL, CABA, CRSP, EDIT, IMTX, IOVA, IPSC, KRYS, MGTX, MRNA, NTLA, PASG, PDSB, PRVB, RCKT, SNTI, SQZ, TNYA, TSHA, VYGR▪ Conducted due diligence and market research on public and private companies in the space including deal analysis (collaborations, licensing, acquisitions), clinical trial, IP, and regulatory landscape analysis, and 20+ KOL interviews ▪ Synthesized and communicated science-driven investment theses in gene editing, cell and gene therapy in >80 written research reports and in oral pitches, including competitive landscape analysis on developing drug candidates▪ Built >5 financial models including scenario and sensitivity analyses to forecast commercial performance using research-driven market sizing, demand, penetration, competition, patient experience and drug pricing assumptions ▪ Led cross-team biweekly meetings, collaborated on, and tracked deliverables for >30 reports on gen med advances

Aug 2022 - Feb 2023

Senior Associate In Biotech Equity Research

New York City, New York, Us

Coverage (Immunology, Oncology, Nephrology, and Rare Disease): KZR, BCRX, CMPI, IDYA, KALV, RZLT, SLDB, TYRA, TCON, AYLA; familiar with AFMD, ALNY, AUPH, CALT, CMRX, DTIL, EIGR, EPIX, FMTX, KPTI, MRTX, MRUS, RARE, SGMO, SRRA, THRX, TVTX, VALN▪ Performed scientific, clinical, and financial due diligence on coverage, including primary research via KOL interviews ▪ Vetted investment banking deals, developed business case, resulting in 2 “go” recommendations and ~$300 million in primary and secondary offerings (TYRA, RZLT) and 2 “no-go” decisions due to outstanding questions around mechanism of action, differentiation from competitors, efficacy/ safety profile and translatability of preclinical data ▪ Synthesized and communicated investment theses and recommendations in >100 written reports and presentations ▪ Built >7 financial models for pipeline valuation and updated >40 models based on companies’ earnings releases

Jul 2021 - Jul 2022

Originator And Lead, Phlaxis

Chicago, Illinois, Us

▪ Assembled and managed team, developed and pitched value story, and forecasted peak revenue of $1.7 billion▪ Managed and authored business, scientific and regulatory docs including pitch decks, patents, grants, manuscripts▪ Performed primary research, via 30+ interviews of stakeholders including industry experts, KOLs, payers, physicians, and parents of food allergic children to understand unmet need in patient population (NSF I-Corps program)▪ Designed novel framework/ go-to-market strategy for introducing food allergy vaccination in high-risk pediatric population▪ Integrated research into actionable insights to optimize vaccine design and implement risk-mitigation strategies ▪ Raised $280k via the Deep Tech Compass Accelerator and competitive Edward L. Kaplan New Venture Challenge

Mar 2020 - Jun 2021

Phd Candidate

Chicago, Illinois, Us

Advisors: Dr. Jeffrey Hubbell, Dr. Melody Swartz▪ Designed a novel biomaterial-based protein delivery system which can be used to induce a targeted and suppressive immune response (inverse vaccine) with applications in the prevention and treatment of autoimmunity and allergies▪ Developed strategic partnerships with academic collaborators and industry partners (Anokion) to advance project▪ Authored Food Allergy Fund Innovators Research Grant which led to $100k in funding in 2020▪ 1st author publication: Maulloo CD, Cao S, Watkins EA, Raczy MM, Solanki AS, Nguyen M, Reda JW, Shim H-N, Wilson DS, Swartz MA and Hubbell JA (2021) Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance. Front. Immunol. 12:714842. doi: 10.3389/fimmu.2021.714842

Dec 2015 - Mar 2021

Teaching Assistant And Lecturer

Chicago, Illinois, Us

Teaching Assistant and Lecturer, The Engineering and Biology of Tissue Repair (Spring 2017)-Led biweekly literature review sessions, exam review sessions, guided graduate and undergraduate students through proposal writing projects, wrote exam questions and graded them for 15-20 students-Taught a lecture on “Skin and Lymphovascular Engineering”Teaching Assistant, Cellular Engineering (Winter 2017)-Led biweekly class material review workshops, guided research project proposals, graded problem sets and exams for 25-30 students

Jan 2017 - Jun 2017

Life Sciences Analyst

▪ Conducted scientific/ financial diligence on public smidcap biotech companies in oncology and respiratory disease ▪ Communicated investment theses and recommendations to portfolio manager in 4 reports and 8 presentations

Oct 2020 - Feb 2021

Undergraduate Researcher

Rochester, Ny, Us

Advisor: Dr. Lisa DeLouise-Characterized and optimized the surface chemistry, and particle stability of Zinc Sulfide quantum dots-Established an on-campus collaboration with Professor Todd Krauss to synthesize the quantum dots-Investigated the coating of mesoporous silica nanoparticles with polyethylinimine and siRNA as a gene-silencing tool

2013 - 2015 ~2 yrs

Chemistry Workshop Leader

Rochester, Ny, Us

Workshop Leader in these following courses: Quantum Chemistry, Physical Chemistry, Inorganic Chemistry, Honors Organic Chemistry-Led weekly review workshops in a number of undergraduate Chemistry courses, conducted small group discussions to guide students through problem-solving and critical thinking exercises, graded problem sets and exams for 30-40 students

2012 - 2015 ~3 yrs

Summer Intern

Boston, Ma, Us

Advisor: Dr. Michael GoldbergSupervised by: Ellese Carmona-Investigated the translational efficiency of modified mRNA untranslated regions compared with endogenous sequences using recombinant cloning tools and quantitative PCR

Jun 2014 - Sep 2014

Summer Intern

Lausanne, Vaud, Ch

Advisor: Dr. Jeffrey HubbellSupervised by: Dr. Daniel Bonner-Established a narrow range of per-particle concentration of antigen and adjuvant that provoked an optimal T cell response, using quantitative flow cytometry and enzyme-linked immunosorbent assay-Successfully functionalized polyethyleneglycol - polypropylenesulfide nanoparticles with antigen and adjuvant, and characterized the particles through dynamic light scattering, zeta potential, BCA & Iodine colorimetric assays

Jul 2013 - Sep 2013
2 education records

Chitavi (Chloe) Maulloo, Ph.D. education

Molecular Engineering, Immunology, Lymphatics

University Of Chicago

Bachelor Of Science (B.S.), Chemistry, Biology

University Of Rochester
FAQ

Frequently asked questions about Chitavi (Chloe) Maulloo, Ph.D.

Quick answers generated from the profile data available on this page.

What company does Chitavi (Chloe) Maulloo, Ph.D. work for?

Chitavi (Chloe) Maulloo, Ph.D. works for IE Business School.

What is Chitavi (Chloe) Maulloo, Ph.D.'s role at IE Business School?

Chitavi (Chloe) Maulloo, Ph.D. is listed as IMBA Candidate at IE Business School.

What is Chitavi (Chloe) Maulloo, Ph.D.'s email address?

AeroLeads has found 1 work email signal at @uchicago.edu for Chitavi (Chloe) Maulloo, Ph.D. at IE Business School.

Where is Chitavi (Chloe) Maulloo, Ph.D. based?

Chitavi (Chloe) Maulloo, Ph.D. is based in New York, United States while working with IE Business School.

What companies has Chitavi (Chloe) Maulloo, Ph.D. worked for?

Chitavi (Chloe) Maulloo, Ph.D. has worked for Ie Business School, Scotiabank - Global Banking And Markets, Chardan, Jefferies, and Polsky Center At The University Of Chicago.

How can I contact Chitavi (Chloe) Maulloo, Ph.D.?

You can use AeroLeads to view verified contact signals for Chitavi (Chloe) Maulloo, Ph.D. at IE Business School, including work email, phone, and LinkedIn data when available.

What schools did Chitavi (Chloe) Maulloo, Ph.D. attend?

Chitavi (Chloe) Maulloo, Ph.D. holds Molecular Engineering, Immunology, Lymphatics from University Of Chicago.

What skills is Chitavi (Chloe) Maulloo, Ph.D. known for?

Chitavi (Chloe) Maulloo, Ph.D. is listed with skills including Cancer Immunology, Nanoparticles, Inorganic Synthesis, Lymphatics, Cell Culture, Matlab, Organic Chemistry, and Statistics.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.